230 related articles for article (PubMed ID: 21351307)
1. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.
Garbe E; Suling M; Kloss S; Lindemann C; Schmid U
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):258-64. PubMed ID: 21351307
[TBL] [Abstract][Full Text] [Related]
2. The Nordic countries as a cohort for pharmacoepidemiological research.
Furu K; Wettermark B; Andersen M; Martikainen JE; Almarsdottir AB; Sørensen HT
Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):86-94. PubMed ID: 19961477
[TBL] [Abstract][Full Text] [Related]
3. Record linkage for pharmacoepidemiological studies in cancer patients.
Herk-Sukel MP; Lemmens VE; Poll-Franse LV; Herings RM; Coebergh JW
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):94-103. PubMed ID: 21812067
[TBL] [Abstract][Full Text] [Related]
4. Individual mortality information in the German Pharmacoepidemiological Research Database (GePaRD): a validation study using a record linkage with a large cancer registry.
Langner I; Ohlmeier C; Zeeb H; Haug U; Riedel O
BMJ Open; 2019 Jul; 9(7):e028223. PubMed ID: 31270118
[TBL] [Abstract][Full Text] [Related]
5. Validating mortality in the German Pharmacoepidemiological Research Database (GePaRD) against a mortality registry.
Ohlmeier C; Langner I; Garbe E; Riedel O
Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):778-84. PubMed ID: 27061445
[TBL] [Abstract][Full Text] [Related]
6. Data safety and drug safety in Germany: a closing gap?
Rathmann W
Pharmacoepidemiol Drug Saf; 2001 Dec; 10(7):625-30. PubMed ID: 11980251
[TBL] [Abstract][Full Text] [Related]
7. Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1137-50. PubMed ID: 20602344
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacoepidemiology. Analysis of drug prescription data].
Gothe H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1145-54. PubMed ID: 18985408
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacoepidemiological research with large health databases].
Andersohn F; Garbe E
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Oct; 51(10):1135-44. PubMed ID: 18985407
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD).
Mikolajczyk RT; Kraut AA; Garbe E
Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):873-80. PubMed ID: 23733705
[TBL] [Abstract][Full Text] [Related]
11. Optimizing an algorithm for the identification and classification of pregnancy outcomes in German claims data.
Wentzell N; Schink T; Haug U; Ulrich S; Niemeyer M; Mikolajczyk R
Pharmacoepidemiol Drug Saf; 2018 Sep; 27(9):1005-1010. PubMed ID: 30022557
[TBL] [Abstract][Full Text] [Related]
12. Pharmacoepidemiological research using French reimbursement databases: yes we can!
Martin-Latry K; Bégaud B
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):256-65. PubMed ID: 20128015
[TBL] [Abstract][Full Text] [Related]
13. Access to linked administrative healthcare utilization data for pharmacoepidemiology and pharmacoeconomics research in Canada: anti-viral drugs as an example.
Rawson NS
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1072-9. PubMed ID: 19650154
[TBL] [Abstract][Full Text] [Related]
14. Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study.
Ohlmeier C; Langner I; Hillebrand K; Schmedt N; Mikolajczyk R; Riedel O; Garbe E
BMC Public Health; 2015 Jun; 15():570. PubMed ID: 26087768
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations.
Pigeot I; Ahrens W
Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):215-23. PubMed ID: 18200610
[TBL] [Abstract][Full Text] [Related]
16. A MiniReview of the use of hospital-based databases in observational inpatient studies of drugs.
Larsen MD; Cars T; Hallas J
Basic Clin Pharmacol Toxicol; 2013 Jan; 112(1):13-8. PubMed ID: 22901097
[TBL] [Abstract][Full Text] [Related]
17. VIDEOFAR: an epidemiologic tool for drug utilization studies.
Raschetti R
Ann Ist Super Sanita; 1991; 27(2):191-3. PubMed ID: 1755569
[TBL] [Abstract][Full Text] [Related]
18. The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months.
Wettermark B; Hammar N; Fored CM; Leimanis A; Otterblad Olausson P; Bergman U; Persson I; Sundström A; Westerholm B; Rosén M
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):726-35. PubMed ID: 16897791
[TBL] [Abstract][Full Text] [Related]
19. Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan.
Cheng CL; Kao YH; Lin SJ; Lee CH; Lai ML
Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):236-42. PubMed ID: 21351304
[TBL] [Abstract][Full Text] [Related]
20. Databases for pediatric medicine research in Europe--assessment and critical appraisal.
Neubert A; Sturkenboom MC; Murray ML; Verhamme KM; Nicolosi A; Giaquinto C; Ceci A; Wong IC;
Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1155-67. PubMed ID: 18979461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
